Access cutting-edge gastroparesis treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access gastroparesis specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastroparesis treatment provided free
The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects. The main questions it aims to answer are: * To evaluate the efficacy of CIN-102 on symptoms of gastroparesis when given to patients with idiopathic gastroparesis compared to a placebo * To evaluate the safety of CIN-102 when given to patients with idiopathic gastroparesis compared to a placebo Partic
Sponsor: CinDome Pharma, Inc.
Check if you qualify for this gastroparesis clinical trial in Little Rock, AR
If you're searching for gastroparesis treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastroparesis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.